Warning! GuruFocus detected
2 Severe warning signs
with HIN.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Heartware International, Inc.
ISIN : AU000000HIN4
Share Class Description:
ASX:HIN: DRCompare
Compare
Traded in other countries / regions
HIN.AustraliaHIY1.Germany Description
Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.96 | |||||
| Equity-to-Asset | 0.39 | |||||
| Debt-to-Equity | 1.14 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 1.75 | |||||
| Beneish M-Score | -2.69 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 27.2 | |||||
| 3-Year EBITDA Growth Rate | -17.4 | |||||
| 3-Year EPS without NRI Growth Rate | -11.9 | |||||
| 3-Year FCF Growth Rate | -58.5 | |||||
| 3-Year Book Growth Rate | 32.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.29 | |||||
| Quick Ratio | 4.54 | |||||
| Days Inventory | 160.93 | |||||
| Days Sales Outstanding | 54.95 | |||||
| Days Payable | 55 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -6.1 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.98 | |||||
| Operating Margin % | -16.99 | |||||
| Net Margin % | -23.03 | |||||
| FCF Margin % | -10.83 | |||||
| ROE % | -31.98 | |||||
| ROA % | -12.88 | |||||
| ROIC % | -28.46 | |||||
| ROC (Joel Greenblatt) % | -92.66 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.92 | |||||
| PB Ratio | 6.01 | |||||
| Price-to-Tangible-Book | 11.85 | |||||
| EV-to-Revenue | 4.08 | |||||
| Price-to-Median-PS-Value | 0.37 | |||||
| Price-to-Net-Current-Asset-Value | 118.5 | |||||
| Earnings Yield (Greenblatt) % | -4.15 | |||||
| FCF Yield % | -2.89 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Heartware International, Inc. Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 352.555 | ||
| EPS (TTM) (A$) | - | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (A$) | - | ||
| 20-Day SMA (A$) | - | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (A$) | 2.36 - 105.84 | ||
| Shares Outstanding (Mil) | 575.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Heartware International, Inc. Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Heartware International, Inc. Stock Events
| Event | Date | Price (A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Heartware International, Inc. Frequently Asked Questions
What is Heartware International, Inc.(ASX:HIN)'s stock price today?
The current price of ASX:HIN is A$2.37. The 52 week high of ASX:HIN is A$105.84 and 52 week low is A$2.36.
When is next earnings date of Heartware International, Inc.(ASX:HIN)?
The next earnings date of Heartware International, Inc.(ASX:HIN) is .
Does Heartware International, Inc.(ASX:HIN) pay dividends? If so, how much?
Heartware International, Inc.(ASX:HIN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers